newsfilter
← Latest News
PR Newswire·

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026

Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced financial...